American Century Companies Inc. Cuts Stock Holdings in Bath & Body Works, Inc. $BBWI

American Century Companies Inc. reduced its stake in Bath & Body Works, Inc. (NYSE:BBWI) by 7.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 284,997 shares of the company’s stock after selling 22,913 shares during the period. American Century Companies Inc. owned approximately 0.13% of Bath & Body Works worth $8,641,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Golden State Wealth Management LLC increased its holdings in Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock worth $40,000 after purchasing an additional 642 shares during the period. UMB Bank n.a. raised its position in Bath & Body Works by 65.9% in the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company’s stock valued at $46,000 after purchasing an additional 596 shares in the last quarter. Ancora Advisors LLC acquired a new stake in Bath & Body Works in the 4th quarter valued at about $67,000. GKV Capital Management Co. Inc. acquired a new stake in Bath & Body Works in the 1st quarter valued at about $69,000. Finally, TD Private Client Wealth LLC raised its position in Bath & Body Works by 44.3% in the 1st quarter. TD Private Client Wealth LLC now owns 3,305 shares of the company’s stock valued at $100,000 after purchasing an additional 1,015 shares in the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Stock Performance

BBWI opened at $31.38 on Wednesday. Bath & Body Works, Inc. has a one year low of $24.94 and a one year high of $41.87. The stock has a market capitalization of $6.64 billion, a P/E ratio of 8.37, a price-to-earnings-growth ratio of 1.04 and a beta of 1.54. The business’s 50-day simple moving average is $30.49 and its 200-day simple moving average is $30.90.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 47.44% and a net margin of 11.10%.The firm had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter last year, the business posted $0.38 EPS. The firm’s quarterly revenue was up 2.9% compared to the same quarter last year. Bath & Body Works has set its Q2 2025 guidance at 0.330-0.380 EPS. On average, equities research analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 5th. Investors of record on Friday, August 22nd will be paid a dividend of $0.20 per share. The ex-dividend date is Friday, August 22nd. This represents a $0.80 dividend on an annualized basis and a yield of 2.5%. Bath & Body Works’s dividend payout ratio is currently 21.33%.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on BBWI. Wells Fargo & Company increased their price target on Bath & Body Works from $40.00 to $44.00 and gave the company an “overweight” rating in a research report on Wednesday, May 14th. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $38.00 price target on shares of Bath & Body Works in a research report on Thursday, August 21st. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the company an “overweight” rating in a research report on Thursday, May 15th. The Goldman Sachs Group reduced their price target on Bath & Body Works from $44.00 to $43.00 and set a “buy” rating on the stock in a research report on Friday, May 30th. Finally, Morgan Stanley dropped their price objective on Bath & Body Works from $49.00 to $43.00 and set an “overweight” rating on the stock in a report on Tuesday, May 6th. Fourteen research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $42.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.